Boston Scientific (NYSE:BSX) is joining the Mayo Clinic and the University of Minnesota in backing startup accelerator Gener8tor as it launches a medtech focused incubator in Minneapolis, according to a new report from the Minneapolis Star Tribune.
The newly launched accelerator will operate under a seven-week program that will support six new startups with a focus on medical technology, requiring no fees or equity and offered three times a year, according to the report.
Initial entrants into the incubator include wearable-focused medical tape maker ExpressionMed, cardiac rhythm and neuromod dev Kobara Medical, interventional assist device dev NeuroVASx, lung disease symptom control dev Quench Medical, snoring-reduction gamified app dev Soundly and diagnostic dev Vitrose Health, according to the Star Tribune.
Companies will be paired with entrepreneurs, investors, venture capitalists and experts to develop their technology and companies. The newly launched incubator builds on a partnership established between Gener8tor and the University of Minnesota in 2016, according to the report.
“The next big ideas in healthcare won’t happen in a vacuum—meaningful innovation is the result of thoughtful collaboration. We look forward to working with these ‘scaling’ companies in Minnesota to identify new opportunities to transform patient care,” Boston Scientific corporate research VP David Knapp said in a prepared statement.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.